These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3501002)

  • 1. Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain.
    Donnan GA; Kaczmarczyk SJ; McKenzie JS; Rowe PJ; Kalnins RM; Mendelsohn FA
    J Neurol Sci; 1987 Nov; 81(2-3):261-71. PubMed ID: 3501002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
    Donnan GA; Kaczmarczyk SJ; Rowe PJ; Figdor R; Mendelsohn FA
    J Neurol Sci; 1986 Jun; 74(1):111-9. PubMed ID: 3487620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine uptake sites in mouse brain: distribution determined by quantitative [3H]mazindol autoradiography.
    Donnan GA; Kaczmarczyk SJ; McKenzie JS; Kalnins RM; Chilco PJ; Mendelsohn FA
    Brain Res; 1989 Dec; 504(1):64-71. PubMed ID: 2598017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
    Ricaurte GA; Langston JW; DeLanney LE; Irwin I; Brooks JD
    Neurosci Lett; 1985 Sep; 59(3):259-64. PubMed ID: 3932903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice.
    Sundström E; Luthman J; Goldstein M; Jonsson G
    Brain Res Bull; 1988 Aug; 21(2):257-63. PubMed ID: 2903784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS
    Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
    Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1986 Nov; 25(11):1231-4. PubMed ID: 3491964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density.
    Joyce JN; Marshall JF; Bankiewicz KS; Kopin IJ; Jacobowitz DM
    Brain Res; 1986 Sep; 382(2):360-4. PubMed ID: 2944565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of neurotensin receptors in MPTP-treated mice.
    Tanji H; Araki T; Fujihara K; Nagasawa H; Itoyama Y
    Peptides; 1999; 20(7):803-7. PubMed ID: 10477079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.
    Alexander GM; Schwartzman RJ; Brainard L; Gordon SW; Grothusen JR
    Brain Res; 1992 Aug; 588(2):261-9. PubMed ID: 1356591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
    Bhargava HN; Perlow MJ
    Toxicol Lett; 1988 Mar; 40(3):219-24. PubMed ID: 3258448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
    Ambrosio S; Gerli P; Perego C; Algeri S
    Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sershen H; Reith ME; Hashim A; Lajtha A
    Eur J Pharmacol; 1984 Jun; 102(1):175-8. PubMed ID: 6332738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA; Rothblat DS; Joyce JN; Schneider JS
    Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
    Tanji H; Araki T; Nagasawa H; Itoyama Y
    Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.